Table 3 Metabolic syndrome components in the case and control groups.

From: Relationship between serum nitric oxide of patients with thyroid disorders and metabolic syndrome indices and nitrate concentration of water

Clinical examinations

Case

Control

P- value

Max

Min

SD ± Mean

Max

Min

SD ± Mean

Height (cm)

186

150

8.31 ± 161.82

188

80

20.22 ± 159.02

0.276

Weight (kg)

100

46

12.59 ± 73.04

100

16

19.37 ± 66.58

0.110

BMI kg/m2))

36.80

18.35

4.62 ± 28.10

37.65

12.62

4.80 ± 25.69

0.012

WC* (cm)

122

75

11.92 ± 97.14

117

21

18.88 ± 86.74

0.004

HDL * (mg/dL)

75

29

9.94 ± 49.52

78

34

9.58 ± 50.70

0.746

FBS (mg/dL)*

192

77

22.51 ± 100.16

295

76

39.56 ± 108.62

0.089

TG (mg/dL)*

435

51

84.06 ± 176.22

258

31

62.69 ± 125.32

0.001

SBP (mm Hg)*

170

100

13.85 ± 118.60

190

80

18.67 ± 120.60

0.677

DBP (mm Hg,)*

100

60

7.27 ± 80.40

130

60

11.37 ± 78.20

0.080

  1. *Metabolic syndrome parameters.
  2. BMI: body mass index, WC: waist circumference; TG: triglyceride; HDL: a high-density lipoprotein; FBS: fasting blood sugar; SBP: systolic blood pressure; DBP: diastolic blood pressure.